tiprankstipranks
Trending News
More News >
NervGen Pharma (NGENF)
OTHER OTC:NGENF
US Market

NervGen Pharma (NGENF) Cash flow

Compare
79 Followers

NervGen Pharma Cash Flow

NGENF's free cash flow for Q3 2025 was C$-5.32M. For the 2025 fiscal year, NGENF's free cash flow was decreased by C$-5.40M and operating cash flow was C$-5.32M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -16.84MC$ -11.30MC$ -17.78MC$ -8.27MC$ -6.31M
Investing Cash Flow
C$ 58.87KC$ -138.85KC$ -21.11KC$ -45.09KC$ -3.42K
Financing Cash Flow
C$ 22.70MC$ 766.28KC$ 22.64MC$ 19.61MC$ 7.85M
End Cash Position
C$ 17.27MC$ 11.66MC$ 22.45MC$ 16.93MC$ 5.60M
Free Cash Flow
C$ -16.84MC$ -11.44MC$ -17.81MC$ -8.31MC$ -6.31M
Currency in CAD

NervGen Pharma Cash Flow